THURSDAY, Jan. 30, 2025 (HealthDay News) -- Weight-loss surgery can protect the liver health of patients with obesity and ...

Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed biotech company ...

The rise of popular weight-loss medications like Ozempic, Wegovy and Manjaro has sparked a new revolution in weight-loss ...

If you’re in a calorie deficit – either from dieting or while taking a weight loss drug – these exercises help direct your ...

A brand new candidate for weight-loss treatment is on the table, with scientists uncovering for the first time how a hormone ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Pranayama, an ancient Indian breathing technique, can aid in weight loss. Here's how former cricketer Navjot Singh Sidhu used ...

There is a range with weight loss patches, but the overarching promise is the same: You stick them on and lose weight as a ...

Salk scientists identify protein BCL6 as a key regulator of muscle maintenance in mice; BCL6-enhancing therapies may prevent ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

Mr Geoppo further suggested that even junk foods don't need to be eliminated, and can be eaten in moderation. He proposed ...